Print Email

Practice Resources  |  Mucositis Study Group

MASCC/ISOO Mucositis Guidelines
©MASCC, Multinational Association for Supportive Care in Cancer™ •  All rights reserved worldwide. 

icon  Main Guidelines Publication

alt MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy alt

Rajesh V. Lalla, Joanne Bowen, Andrei Barasch, Linda Elting, Joel Epstein, Dorothy M. Keefe, Deborah B. McGuire, Cesar Migliorati, Ourania Nicolatou-Galitis, Douglas E. Peterson, Judith E. Raber-Durlacher, Stephen T. Sonis, Sharon Elad and The Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO).
This article was first published online: 25 FEB 2014 | DOI: 10.1002/cncr.28592

Erratum- Practice Guidelines

icon Guidelines Summary

alt MASCC/ISOO Guidelines Summary alt  (Updated 7, Nov, 2014)
 Mucositis Guidelines ©2014 MASCC, Multinational Association of Supportive Care in Cancer™ •  All rights reserved worldwide.

A major effort of the Mucositis Study Group of MASCC/ISOO has been a comprehensive review of the literature related to mucositis and the development of evidence-based clinical practice guidelines. The first set of MASCC/ISOO Mucositis Guidelines was published in the journal Cancer in 2004. The first update of these guidelines was described in publications in 2006-2007. The most recent update is now available here at the MASCC website. This includes a summary paper published in Cancer 2014 and available via open access. In addition, a set of publications in Supportive Care in Cancer describes detailed results for different categories of interventions for mucositis.

icon Translations  -  Translation Policy  •  Or for more translation information please contact Anne Young at ayoung@mascc.org 

Mucositis Practice Guidelines Included in the National Guideline Clearinghouse
These guidelines have recently been included in the National Guideline Clearinghouse™ (NGC). The NGC is a database of evidence-based clinical practice guidelines and related documents, maintained as a public resource by the US Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services. Inclusion in the NGC is contingent on meeting rigorous criteria, including evidence of a systematic literature review, systematically developed recommendations for optimal care in specific clinical circumstances, and an assessment of the benefits and harms of recommended care. 

Publications

>>View All Publications related to current and previous versions of the Guidelines

Current Guideline Publications
FREE open access to the following articles

MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy alt
This article was first published online: 25 FEB 2014 | DOI: 10.1002/cncr.28592

The MASCC/ISOO Mucositis Guidelines: dissemination and clinical impact  - Lalla RV, Ashbury FD. 
 
Systematic review of basic oral care for the management of oral mucositis in cancer patients  - McGuire DB, Fulton JS, Park J, Brown CG, Correa ME, Eilers J, Elad S, Gibson F, Oberle-Edwards LK, Bowen J, Lalla RV

Systematic Review of Anti-inflammatory Agents for the Management of Oral Mucositis in Cancer Patients
Nicolatou-Galitis O, Sarri T, Bowen J, Di Palma M, Kouloulias E, Niscola P, Riesenbeck D, Stokman M, Tissing W, Yeoh E, Elad S, Lalla RV
 
Systematic Review of Antimicrobials, Mucosal Coating Agents, Anesthetics, and Analgesics, for the Management of Oral Mucositis in Cancer Patients  - Saunders D, Epstein JB; Elad S; Allemano J; Bossi P; van de Wetering MD; Rao NG; Potting C; Cheng KK; Freidank A; Brennan MT; Dennis K; Bowen J; Lalla R
 
Systematic review of natural agents for the management of oral mucositis in cancer patients  - Yarom N, Ariyawardana A, Hovan A, Barasch A, Jarvis V, Jensen SB, Zadik Y, Elad S, Bowen J, Lalla RV

Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients  - Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S
 
Emerging Evidence on the Pathobiology of Mucositis  - Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, Logan RM, Nair RG, Stringer AM, Yazbeck R, Elad S, Lalla RV
 
Risk of Oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis  - Elting LS, Chang YC, Parelkar P et al

Supportive Care in Cancer, Volume 21, Issue 11, November 2013, ISSN: 0941-4355 (Print) 1433-7339 (Online)


For Questions or additional information, contact Executive Director, Åge Schultz,  aschultz@mascc.org